Clinical psychology and cardiovascular disease: An up-to-date clinical practice review for assessment and treatment of anxiety and depression

Clinical Practice and Epidemiology in Mental Health

Volumn 7, Issue , 2011, Pages 148-156

  Compare, Angelo ^a   Germani, Elena ^b   Proietti, Riccardo ^c   Janeway, David ^d  

^a UNIVERSITY OF BERGAMO   (Italy)

^b Centro Diagnostico Italiano   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Anxiety; Cardiovascular disease; Depression; Heart disease; Psychocardiology; Psychological risk factors; Psychological treatments

Indexed keywords

CITALOPRAM; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE;

ACUTE HEART INFARCTION; ANXIETY DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL PSYCHOLOGY; COGNITIVE THERAPY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL SOCIETY; PROGNOSIS; PSYCHOLOGICAL WELL BEING; PSYCHOTHERAPY; QUESTIONNAIRE; REVIEW; RISK REDUCTION;

EID: 84859891400     PISSN: None     EISSN: 17450179     Source Type: Journal    
DOI: 10.2174/1745017901107010148     Document Type: Review

References (87)

1. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161: 1849-56. (Pubitemid 32762729)
2. Molinari E, Compare A, Parati G, Eds. Clinical psychology and heart disease. New York: Springer 2006.
3. Zuidersma M, Thombs BD, de Jonge P. Onset and Recurrence of depression as predictors of cardiovascular prognosis in depressed acute coronary syndrome patients: A systematic review. Psychother Psychosom 2011; 80: 227-37.
4. Janszky I, Ahnve S, Lundberg I, et al. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol 2010; 56: 31-7.
5. Whang W, Shimbo D, Kronish IM, et al. Depressive symptoms and all-cause mortality in unstable angina pectoris (from the Coronary Psychosocial Evaluation Studies [COPES]). Am J Cardiol 2010; 106: 1104-7.
6. Nabi H, Shipley MJ, Vahtera J, et al. Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart 2010; 96:1645-50.
7. Watkins LL, Blumenthal JA, Babyak MA, et al. Phobic anxiety and increased risk of mortality in coronary heart disease. Psychosom Med 2010; 72: 664-71.
8. Kubzansky LD, Kawachi I, Weiss ST, et al. Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med 1998; 20: 47-58. (Pubitemid 29071466)
9. Moser DK, De Jong, M.J. Anxiety and heart disease. In: Molinari E, Compare, A., Parati, G., Eds. Clinical psychology and heart Disease. Springer-Verlag Italia 2006.
10. Barlow D. Anxiety and its disorders. New York: Guilford 1988.
11. Shah SU, White A, White S, et al. Heart and mind: (1) relationship between cardiovascular and psychiatric conditions. Postgrad Med J 2004; 80: 683-9. (Pubitemid 39627098)
12. Roest AM, Martens EJ, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010; 56: 38-46.
13. Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994; 90: 2225-9. (Pubitemid 24354305)
14. Rose SK, Conn VS, Rodeman BJ. Anxiety and self-care following myocardial infarction. Issues Ment Health Nurs 1994; 15: 433-44.
15. Zafar MU, Paz-Yepes M, Shimbo D, et al. Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J 2010; 31: 1573-82.
16. Fehder W. Alterations in immune response associated with anxiety in surgical patients. CRNA 1999; 10: 124-9. (Pubitemid 29439750)
17. Wittstein IS. Depression, anxiety, and platelet reactivity in patients with coronary heart disease. Eur Heart J 2010; 31: 1548-50.
18. th ed. Washington, DC 2000.
19. Carney R, Freeland KE, Elsen SA, Rich MW, Jaffe AS. Major Depression And Medication Adherence In Elder Patients With Coronary Artery Disease. Health Psychology 1995; 14: 88-90.
20. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005.
21. Kop WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med 1999; 61: 476-87. (Pubitemid 29360311)
22. Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom Res 2000; 48: 379-91. (Pubitemid 30433396)
23. Roest AM, Thombs BD, Grace SL, et al. Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality. J Affect Disord 2011; 131: 158-63.
24. de Jonge P, Ormel J, van den Brink RH, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 2006; 163: 138-44. (Pubitemid 43050115)
25. Smolderen KG, Spertus JA, Reid KJ, et al. The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes 2009; 2: 328-37.
26. Martens EJ, Hoen PW, Mittelhaeuser M, et al. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 2010; 40: 807-14.
27. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66: 814-22. (Pubitemid 39552863)
28. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379-88.
29. Compare A, Gondoni L, Molinari E. Psychological risk factors for cardiac disease and pathophysiological mechanisms: an overview. In: Molinari E, Compare A, Parati G, Eds. Clinical psychology and heart disease. New York: Springer 2006: pp. 21-32.
30. Kop WJ, Ader, D.N. Depression in coronary artery disease: Assessment And Treatment. In: Molinari E, Compare, A., Parati, G., Eds. Clinical psychology and heart disease: Springer-Verlag Italia 2006.
31. Rozanski A, Blumenthal JA, Davidson KW, et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005; 45: 637-51. (Pubitemid 40278960)
32. Denollet J, Pedersen SS. Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk. J Am Coll Cardiol 2009; 53: 947-9.
33. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151-69.
34. Beck AT, Rush AJ, Shaw BF, et al. Cognitive therapy of depression. New York: Guilford Press 1979.
35. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988; 50: 627-33. (Pubitemid 19016813)
36. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270: 1819-25. (Pubitemid 23301435)
37. Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol 1995; 14: 388-98.
38. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1(3): 385-401.
39. Schulz R, Beach SR, Ives DG, et al. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2000; 160: 1761-8. (Pubitemid 30418812)
40. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41. (Pubitemid 27095712)
41. Appels A. Loss of control, vital exhaustion and coronary heart disease: stress, personal control, and health. Brussels LJWAS, ed. In Steptoe A, Appels Ad, Eds. Oxford; England 1989; pp. 215-235.
42. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13. (Pubitemid 32823891)
43. Lowe B, Unutzer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 2004; 42: 1194-201. (Pubitemid 39627296)
44. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003; 41: 1284-92.
45. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994; 272: 1749-56. (Pubitemid 24372002)
46. Freedland KE, Skala JA, Carney RM, et al. The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med 2002;64:897-905. (Pubitemid 35417133)
47. Maier K, Chatkoff, D, Burg, M.M. Depression and CHD: prevalence, prognosis; pathology and treatment. In: Molinari E, Compare, A., Parati, G., Eds. Clinical psychology and heart disease: Springer-Verlag Italia 2006.
48. Lichtman JH, Bigger JT, Jr., Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008; 118: 1768-75.
49. Pozuelo L, Tesar G, Zhang J, et al. Depression and heart disease: what do we know, and where are we headed? Cleve Clin J Med 2009; 76: 59-70.
50. Dimsdale JE. What does heart disease have to do with anxiety? J Am Coll Cardiol 2010; 56: 47-8.
51. Beck AT, Steer RA. Manual for the beck anxiety inventory. San Antonio, TX: The Psychological Corporation 1990.
52. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-9.
53. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
54. Grossi E, Groth N, Mosconi P, et al. Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S). Health Qual Life Outcomes 2006;4:88.
55. Klocek M, Kubinyi A, Bacior B, et al. Effect of physical training on quality of life and oxygen consumption in patients with congestive heart failure. Int J Cardiol 2005; 103: 323-9. (Pubitemid 41132603)
56. Manzoni GM, Villa V, Compare A, et al. Short-term effects of a multi-disciplinary cardiac rehabilitation programme on psychological well-being, exercise capacity and weight in a sample of obese in-patients with coronary heart disease: a practice-level study. Psychol Health Med 2011; 16: 178-89.
57. Frasure-Smith N, Lesperance F, Prince RH, et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 1997; 350: 473-9. (Pubitemid 27343302)
58. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-91. (Pubitemid 28071019)
59. Nelson JC, Kennedy JS, Pollock BG, et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry 1999; 156: 1024-8. (Pubitemid 29302794)
60. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients enrichd randomized trial. JAMA 2003; 289(23): 3106-16.
61. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-9. (Pubitemid 34848222)
62. van den Brink RH, van Melle JP, Honig A, et al. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT). Am Heart J 2002; 144: 219-25. (Pubitemid 34879642)
63. Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297: 367-79. (Pubitemid 46155798)
64. van Melle JP, de Jonge P, Honig A, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007; 190: 460-6. (Pubitemid 46868827)
65. Dusseldorp E, van Elderen T, Maes S, et al. A meta-analysis of psychoeduational programs for coronary heart disease patients. Health Psychol 1999; 18: 506-19. (Pubitemid 29468523)
66. Linden W. Psychological treatments in cardiac rehabilitation: review of rationales and outcomes. J Psychosom Res 2000;48:443-54. (Pubitemid 30433401)
67. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996; 156: 745-52. (Pubitemid 26108196)
68. Sebregts EH, Falger PR, Bar FW. Risk factor modification through nonpharmacological interventions in patients with coronary heart disease. J Psychosom Res 2000;48:425-41. (Pubitemid 30433400)
69. Sebregts EH, Falger PR, Appels A, et al. Psychological effects of a short behavior modification program in patients with acute myocardial infarction or coronary artery bypass grafting: a randomized controlled trial. J Psychosom Res 2005; 58: 417-24. (Pubitemid 40982203)
70. Gould KL, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995; 274: 894-901.
71. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-33. (Pubitemid 20224971)
72. Friedman M, Thoresen CE, Gill JJ, et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J 1986; 112: 653-65. (Pubitemid 16025026)
73. Ornish D, Brown SE, Billings JH, et al. Can lifestyle changes reverse coronary atherosclerosis? Four year results of the Lifestyle Heart Trial, (abstract). Circulation 1993; 88: 385.
74. Edelman D, Oddone EZ, Liebowitz RS, et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. J Gen Intern Med 2006;21:728-34. (Pubitemid 43973558)
75. Hellman CJ, Budd M, Borysenko J, et al. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med 1990; 16: 165-73.
76. Barlow DH, Gorman JM, Shear MK, et al. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA 2000; 283: 2529-36. (Pubitemid 30324195)
77. Otto MW, Pollack MH, Sachs GS, et al. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry 1993; 150: 1485-90. (Pubitemid 23289304)
78. Hollon SD, Munoz RF, Barlow DH, et al. Psychosocial intervention development for the prevention and treatment of depression: promoting innovation and increasing access. Biol Psychiatry 2002; 52: 610-30. (Pubitemid 35284024)
79. Klerman G, Weissman M, Rounseville B, Chevron E. Interpersonal psychotherapy of depression. New York: Basic Books 1984.
80. Weissman MM, Prusoff BA, Dimascio A, et al. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry 1979; 136: 555-8. (Pubitemid 9183112)
81. Koszycki D. Interpersonal psychoterapy for depression in patients with coronary heart disease. In: Molinari E, Compare A, Parati G, Eds. Clinical psychology and heart disease: springer-verlag: italia 2006.
82. Weissman MM, Markowitz, J.C, Klerman G.L. Comprehensive Guide To Interpersonal Psychotherapy. New York: Basic Books 2000.
83. Weissman MM, Klerman GL, Prusoff BA, et al. Depressed outpatients. Results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiatry 1981; 38: 51-5. (Pubitemid 11156712)
84. Greenland P, Alpert JS, Beller GA, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010; 56: e50-103.
85. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010;122:e584-636.
86. Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 2003; 60: 627-36. (Pubitemid 36682320)
87. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004;66: 466-74. (Pubitemid 38971239)